Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy-Reference-Cited by-同舟云学术

Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy

Published:1990-05 Issue:3 Volume:32 Page:143-153
ISSN:0340-7004
Container-title:Cancer Immunology Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Bartik Mary M.,Ahn Mi-Chung,Baumgartel Barbara A.,Hendricks Robert L.,Mokyr Margalit B.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/BF01771449.pdf

Reference34 articles.

1. Barker E, Mokyr MB (1988) Importance of Lyt 2+ T-cells in the resistance of melphalan cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells. Cancer Res 48: 4834

2. Bartik MM, Takesue BY, Mokyr MB (1987) Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor. Cancer Res 47: 4848

3. Ben-Efraim S, Bocian RC, Mokyr MB, Dray S (1985) Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth. Cancer Immunol Immunother 15: 101

4. Bocian RC, Ben-Efraim S, Dray S, Mokyr MB (1984) Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother 18: 41

5. Burton RC (1986) Frequency of murine cytotoxic T cell precursors reactive to plasma cell tumour-associated antigens as compared to major histocompatibility antigens. Aust J Exp Med Biol Sci 64: 323

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulating Anticancer Alkylating Drugs: Targets and Mechanisms of Activity;Current Drug Targets;2001-06-01

2. B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cells;Cancer Immunology, Immunotherapy;2000-03-17

3. Signaling through CD40 enhances cytotoxic T lymphocyte generation by CD8 + T cells from mice bearing large tumors;Cancer Immunology, Immunotherapy;1999-04-12

4. Importance of the B7-2 Molecule for Low Dose Melphalan-Induced Acquisition of Tumor-Eradicating Immunity by Mice Bearing a Large MOPC-315 Tumor;The Journal of Immunology;1998-02-15

5. Non-Specific Exogenous Immunomodulator in Oncology;Principles of Cancer Biotherapy;1998